Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels

Detalhes bibliográficos
Main Authors:	Hopewell, J, Clarke, R, Seedorf, U, Farrall, M, Hamsten, A, Collins, R, Watkins, H, Consortium, PROCARDIS
Formato:	Journal article
Publicado em:	2010

Registos relacionados

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
Por: Hopewell, J, et al.
Publicado em: (2014)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
Por: Hopewell, J, et al.
Publicado em: (2014)

Oxidized phospholipids, Lp(a) and coronary heart disease risk
Por: Clarke, R, et al.
Publicado em: (2012)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
Por: Kyriakou, T, et al.
Publicado em: (2014)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
Por: Kyriakou, T, et al.
Publicado em: (2014)

Independent relevance of renal function for coronary artery disease
Por: Hopewell, J, et al.
Publicado em: (2010)

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
Por: Clarke, R, et al.
Publicado em: (2018)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Por: Clarke, R, et al.
Publicado em: (2009)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
Por: Parish, S, et al.
Publicado em: (2018)

Genetic Variants in Lp(a) Lipoprotein and Coronary Disease REPLY
Por: Farrall, M, et al.
Publicado em: (2010)

Independent Relevance of Cytokines for Risk of Coronary Heart Disease
Por: Clarke, R, et al.
Publicado em: (2012)

Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease
Por: Clarke, R, et al.
Publicado em: (2009)

ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP
Por: Goel, A, et al.
Publicado em: (2009)

LPA NULL MUTATION GENOTYPING AND QPCR ANALYSIS REFINE KRINGLE ISOFORM ANALYSIS OF LP(A) LEVELS
Por: Kyriakou, T, et al.
Publicado em: (2014)

COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE
Por: Seedorf, U, et al.
Publicado em: (2010)

Apolipoprotein proteomics for residual lipid-related risk in coronary heart disease
Por: Clarke, R, et al.
Publicado em: (2023)

Plasma lipoproteins: apolipoprotein structure and function.
Por: R W Mahley, et al.
Publicado em: (1984-12-01)

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis
Por: K. I. Tebloev, et al.
Publicado em: (2005-10-01)

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
Por: Farrer, M, et al.
Publicado em: (1994)

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Por: Ruotolo, G, et al.
Publicado em: (1998)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
Por: Hopewell, J, et al.
Publicado em: (2011)

Evidence from a family based study of gene association of lymphotoxin alpha with coronary artery disease (CAD)
Por: Green, F, et al.
Publicado em: (2004)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
Por: Dick C. Chan, et al.
Publicado em: (2019-04-01)

Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
Por: R W Mahley, et al.
Publicado em: (1995-04-01)

A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein
Por: Ferdinand M. van 't Hooft, et al.
Publicado em: (1999-09-01)

Influence of polyunsaturated fats on composition of plasma lipoproteins and apolipoproteins
Por: G L Vega, et al.
Publicado em: (1982-08-01)

Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Por: Björkegren, J, et al.
Publicado em: (1998)

Rat plasma lipoproteins and apolipoproteins in experimental hypothyroidism.
Por: L Dory, et al.
Publicado em: (1981-02-01)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
Por: Yahui Lin, et al.
Publicado em: (2022-02-01)

Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
Por: G L Vega, et al.
Publicado em: (1984-06-01)

The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
Por: Hopewell, J, et al.
Publicado em: (2012)

Apolipoproteins and the structural organization of plasma lipoproteins: human plasma high density lipoprotein-3.
Por: C Edelstein, et al.
Publicado em: (1979-02-01)

Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
Por: Junfeng Zhang, et al.
Publicado em: (2023-11-01)

Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
Por: Waldomiro Carlos Manfroi, et al.
Publicado em: (1999-06-01)

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
Por: Kuo-Liong Chien, et al.
Publicado em: (2007-11-01)

Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
Por: Anastasiya Matveyenko, et al.
Publicado em: (2023-03-01)

Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency
Por: S Bijvoet, et al.
Publicado em: (1996-03-01)

Alterations in plasma lipoproteins and apolipoproteins in experimental allergic encephalomyelitis.
Por: V G Shore, et al.
Publicado em: (1987-02-01)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
Por: Karpe, F, et al.
Publicado em: (1994)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
Por: F Karpe, et al.
Publicado em: (1994-07-01)